Altimmune ALT Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's change in accrued liabilities?
- Altimmune (ALT) reported change in accrued liabilities of -$2.49M in Q1 2026.
- How has Altimmune's change in accrued liabilities changed year-over-year?
- Altimmune's change in accrued liabilities decreased by 46.7% year-over-year, from -$1.7M to -$2.49M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.